Gerald Schmid

1.0k citations

27 papers · 889 indexed · h-index 16

Impact in

Oncology top 10%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
Transplantation top 10%

Papers in ⓘ

Oncology 19
- Cancer-related Molecular Pathways 15
- PARP inhibition in cancer therapy 6
Aging 1

Co-authors: Józefa Węsierska‐Gądek (12 shared papers)Markus Guba (4 shared papers)Karl‐Walter Jauch (4 shared papers)Christiane J. Bruns (4 shared papers)Christa Cerni (1 shared paper)Jacek Wojciechowski (3 shared papers)Ivan Ischenko (3 shared papers)A. Papyan (3 shared papers)
Journals: Journal of Cellular Biochemistry (10 papers)Biochemical and Biophysical Research Communications (2 papers)Journal of Cellular Physiology (1 paper)Digestive Diseases (1 paper)Gut (1 paper)
Partner nations: Austria Germany France

In The Last Decade

Gerald Schmid

27 papers receiving 876 citations

Peers

Countries citing papers authored by Gerald Schmid

Since Specialization

Citations

This map shows the geographic impact of Gerald Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Schmid more than expected).

Fields of papers citing papers by Gerald Schmid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Schmid. The network helps show where Gerald Schmid may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerald Schmid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerald Schmid Line = papers co-authored together Gerald Schmid links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis. PubMed ·Valérie Dumon-Jones, Pierre‐Olivier Frappart, Wei‐Min Tong, Giangadharan Sajithlal, Wolfgang Hulla, Gerald Schmid, Zdenko Herceg, Martin Digweed, Zhao-Qi Wang	2003	114
2	Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF Blood ·Markus Guba, Maksim Yezhelyev, Martin Eichhorn, Gerald Schmid, Ivan Ischenko, A. Papyan, Christian Graeb, Hendrik Seeliger, Edward K. Geissler, Karl‐Walter Jauch, Christiane J. Bruns	2005	109
3	Concentration of Insulin-Like Growth Factor (IGF)-I and -II in Iliac Crest Bone Matrix from Pre- and Postmenopausal Women: Relationship to Age, Menopause, Bone Turnover, Bone Volume, and Circulating IGFs1 The Journal of Clinical Endocrinology & Metabolism ·Thomas Seck, Beate Scheppach, S.H. Scharla, Ingo Diel, Werner Blum, H Bismar, Gerald Schmid, B. Krempien, Reinhard Ziegler, Johannes Pfeilschifter	1998	71
4	ADP-Ribosylation of Wild-Type p53in Vitro:Binding of p53 Protein to Specific p53 Consensus Sequence Prevents Its Modification Biochemical and Biophysical Research Communications ·Józefa Węsierska‐Gądek, Gerald Schmid, Christa Cerni	1996	67
5	Concentration of Transforming Growth Factor Beta in Human Bone Tissue: Relationship to Age, Menopause, Bone Turnover, and Bone Volume Journal of Bone and Mineral Research ·Johannes Pfeilschifter, Ingo Diel, Beate Scheppach, Anette Bretz, R. Krempien, Johannes Erdmann, Gerald Schmid, Nicole Reske, H Bismar, Thomas Seck, B. Krempien, Reinhard Ziegler	1998	66
6	The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1‐phosphate receptor 1 Journal of Cellular Biochemistry ·Gerald Schmid, Markus Guba, Ivan Ischenko, A. Papyan, Mareile Joka, Sabine Schrepfer, Christiane J. Bruns, Karl‐Walter Jauch, Christopher Heeschen, Christian Graeb	2007	59
7	Overexpressed poly(ADP-ribose) polymerase delays the release of rat cells from p53-mediated G1 checkpoint Journal of Cellular Biochemistry ·J�zefa W sierska-G dek, Gerald Schmid	2000	54
8	Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer Angiogenesis ·Ivan Ischenko, Markus Guba, Maksim Yezhelyev, A. Papyan, Gerald Schmid, Tim Green, Michael Fennell, Karl‐Walter Jauch, Christiane J. Bruns	2007	44
9	MSH3-Deficiency Initiates EMAST without Oncogenic Transformation of Human Colon Epithelial Cells PLoS ONE ·Christoph Campregher, Gerald Schmid, Franziska Ferk, Siegfried Knasmüller, Vineeta Khare, Benedikt Kortüm, Kyle Dammann, Michaela Lang, Theresa Scharl, Andreas Spittler, Andres I. Roig, Jerry W. Shay, Christopher Gerner, Christoph Gasché	2012	44
10	Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: A novel approach for tailored immunosuppressive therapy Kidney International ·Bertram Hartmann, Gerald Schmid, Christian Graeb, Christiane J. Bruns, Michael Fischereder, Karl‐Walter Jauch, Christopher Heeschen, Markus Guba	2005	35
11	Dual action of the inhibitors of cyclin-dependent kinases: targeting of the cell-cycle progression and activation of wild-type p53 protein Expert Opinion on Investigational Drugs ·Józefa Węsierska‐Gądek, Gerald Schmid	2005	30
12	Central and carboxy‐terminal regions of human p53 protein are essential for interaction and complex formation with PARP‐1 Journal of Cellular Biochemistry ·Józefa Węsierska‐Gądek, Jacek Wojciechowski, Gerald Schmid	2003	29
13	Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP‐1 Journal of Cellular Biochemistry ·Józefa Węsierska‐Gądek, Jacek Wojciechowski, Gerald Schmid	2003	27
14	Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2 ^loxP/loxP Villin-Cre mice Gut ·Benedikt Kortüm, Christoph Campregher, Michaela Lang, Vineeta Khare, Matthias Pinter, Rayko Evstatiev, Gerald Schmid, Martina Mittlböck, Theresa Scharl, Melanie H. Kucherlapati, Winfried Edelmann, Christoph Gasché	2014	26
15	Compensatory Expression of p73 in PARP-Deficient Mouse Fibroblasts as Response to a Reduced Level of Regularly Spliced Wild-Type p53 Protein Biochemical and Biophysical Research Communications ·Gerald Schmid, Zhao-Qi Wang, Józefa Węsierska‐Gądek	1999	23
16	Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence Journal of Cellular Biochemistry ·Gerald Schmid, Matthias P. Kramer, Margarita Maurer‐Granofszky, Stefanie Wandl, Józefa Węsierska‐Gądek	2007	16
17	Identification of PMN-released mutagenic factors in a co-culture model for colitis-associated cancer Carcinogenesis ·Nicolas Granofszky, Michaela Lang, Vineeta Khare, Gerald Schmid, Theresa Scharl, Franziska Ferk, Kristine Jimenez, Siegfried Knasmüller, Christoph Campregher, Christoph Gasché	2017	15
18	Interplay Between the p53 Tumor Suppressor Protein Family and Cdk5: Novel Therapeutic Approaches for the Treatment of Neurodegenerative Diseases Using Selective Cdk Inhibitors Molecular Neurobiology ·Józefa Węsierska‐Gądek, Joanna B. Strosznajder, Gerald Schmid	2006	13
19	Signaling of DNA damage is not sufficient to induce p53 response: (Re)Activation of wt p53 protein strongly depends on cellular context Journal of Cellular Biochemistry ·Józefa Węsierska‐Gądek, Marieta Gueorguieva, Oxana Komina, Gerald Schmid, Matthias P. Kramer	2007	8
20	A combined treatment of HeLa cells with the farnesyl protein transferase inhibitor L‐744,832 and cisplatin significantly increases the therapeutic effect as compared to cisplatin monotherapy Journal of Cellular Biochemistry ·Józefa Węsierska‐Gądek, Matthias P. Kramer, Gerald Schmid	2007	8

About Gerald Schmid

Gerald Schmid is a scholar working on Oncology, Aging, Transplantation, Biotechnology and Pathology and Forensic Medicine, having authored 27 papers that have together received 889 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (15 papers), PARP inhibition in cancer therapy (6 papers), DNA Repair Mechanisms (5 papers), Cell death mechanisms and regulation (5 papers), Genetic factors in colorectal cancer (3 papers), Cancer Research and Treatments (3 papers), Microtubule and mitosis dynamics (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Oncology (387 citations), Transplantation (33 citations), Cancer Research (145 citations), Molecular Biology (578 citations) and Physiology (23 citations). Gerald Schmid has collaborated with scholars based in Austria, Germany and France. Frequent co-authors include Józefa Węsierska‐Gądek, Markus Guba, Karl‐Walter Jauch, Christiane J. Bruns, Christa Cerni, Jacek Wojciechowski, Ivan Ischenko, A. Papyan, Christian Graeb and Maksim Yezhelyev. Their work appears in journals such as Journal of Cellular Biochemistry, Biochemical and Biophysical Research Communications, Journal of Cellular Physiology, Digestive Diseases and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact